Sign in

CIK 0001828673

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

HCW Biologics Inc.

Sign in to watch
Ticker
HCWB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825024477
Phone
+1 954-842-2024
Business address
2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Chief Financial Officer bought 66,452 shares at an average $2.42 ($160,798)
  4. 4 Open-market buy Chief Executive Officer bought 1,520 shares at $2.19 ($3,326)
  5. 4 Open-market buy Director bought 3,500 shares at an average $2.19 ($7,673)
  6. 4 Open-market buy Chief Executive Officer bought 3,000 shares at an average $2.27 ($6,800)
  7. 4 Open-market buy Director bought 2,000 shares at an average $2.11 ($4,227)
  8. 4 Open-market buy Director bought 4,800 shares at $2.09 ($10,041)
  9. 4 Option exercise VP of Development acquired 14,570 shares (option exercise)
  10. 4 Option exercise See Remarks acquired 1,715 shares (option exercise)
  11. 4 Open-market buy VP of Development bought 10,000 shares at $2.42 ($24,150)
  12. 4 Option exercise SVP of Business Development acquired 4,285 shares (option exercise)
  13. 4 Option exercise Chief Financial Officer acquired 27,000 shares (option exercise)
  14. 4/A Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4/A Open-market buy Chief Executive Officer bought 5,830 shares at $3.94 ($22,970)
  20. 4/A Open-market buy Chief Executive Officer bought 8,000 shares at $3.76 ($30,100)

Page 4 of 6 · 109 filings